Institutional flow

Institutional Flow — Scan of Jun 20, 2026

Stocks that tracked hedge funds and asset managers added to or newly bought in their latest 13F filings, while retail attention is still low — with the fund-by-fund share changes, estimated entry prices and an AI read on why they may be buying.

Next scan: tomorrow by 9:00 AM ET. A new scan is posted every Saturday by 9:00 AM ET.
5stocks qualified
4funds adding
5new positions
$1.24Bheld by those funds

AIThis scan

Comparing 13F-HR filings for period-of-report 2026-03-31 vs 2025-12-31 across the five-fund watchlist (Berkshire, Bridgewater, Renaissance, Citadel, Two Sigma), 1,467 manager-tickers showed Q/Q acceleration. After excluding mega-caps, sub-$1B caps, ADR-only foreign listings, single-fund-dominated block buys (>80% from one non-Berkshire filer), positions inside the 7-trading-day earnings blackout, and tickers with elevated retail attention, five US-listed names cleared all rails. The single most surprising finding: PACCAR (PCAR) is a new Bridgewater position of ~777K shares, with Bridgewater, Renaissance, Citadel and Two Sigma all adding into the same name — coincident accumulation by a macro hedge AND three quant shops in a sleepy heavy-truck OEM is unusual, and the obvious read-through is positioning for the 2027 EPA NOx pre-buy cycle that the sell-side has not yet fully reflected. Berkshire was largely a story of trims this quarter (Chevron -35%, Nucor -39%, Bank of America small, exits of Charter/Mastercard/Visa/UNH/Allegion/AON), with the only large incremental adds being Alphabet, Lennar, Delta, NYT and a small Macy's restart — none of which qualified here on the cross-fund / low-retail filters.

How this scan was run

Per-CUSIP per-fund Q/Q delta was computed from fetch_13f_holdings (latest two 13F-HR filings, periods 2026-03-31 and 2025-12-31). All five funds returned both filings successfully; no fund failures this run. A CUSIP qualified as "accelerating" when net adders exceeded net trimmers AND either (a) aggregate share count rose ≥25% Q/Q or (b) ≥2 funds opened new positions. Put-option holdings were stripped from the share aggregation; call holdings counted. Positions where one non-Berkshire filer accounted for >80% of the aggregate share increase were filtered out as block-buy noise — this eliminated GE HealthCare (Citadel 81.5%), Zimmer Biomet (Citadel 91.5%) and several others. Bridgewater participation was used as a tiebreaker on the assumption that the macro book moves slower than quant books (RenTech/Two Sigma/Citadel intra-quarter turnover degrades 13F signal). Alphabet was set aside despite Berkshire's notable +204% Class A add because the position is now a top-five mega-cap retail favorite. CUSIP→ticker resolution was unambiguous for all five finalists; Lennar's dual share class did not appear in the shortlist. Live prices, market caps and earnings dates were verified via Tradier and web search.

#1

PCAR

PACCAR Inc
IndustrialsMkt cap $63.0BNext earnings Jul 28, 2026
Price
$118.95
Est. fund entry
$115.50+3.0%
Shares held
1.91M
Position value
$220.8M
Funds that added
FundPrior sharesShares nowChange
Bridgewater Associates—777.1KNew position
Renaissance Technologies—123.1KNew position
Citadel Advisors429.9K777.9K+81.0%
Two Sigma Investments57.2K233.5K+308.5%
Retail attention 4 of 4 signals quiet
Google Trends15/100quiet
News, 30 days12 articlesquiet
Call/put OI1.30quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Four of the five watchlist managers added in Q1, two of them new — including Bridgewater opening a ~777K-share position. The macro signal lines up with a hard catalyst: model-year 2027 heavy-duty trucks must meet the EPA's 0.035 g/hp-hr NOx standard, and fleets have begun pre-buying compliant Class 8 units ahead of the cost step-up (industry estimates put the per-tractor delta at $20-30K). PACCAR's December order book already showed Class 8 bookings up 21% Y/Y, and management has guided to two new proprietary engine platforms. The pre-buy typically front-loads the cycle into the back half of the year before the regulation takes effect — a setup the sell-side has been slow to model because Q4 2025 truck demand was weak.

What would prove it wrong

If freight rates stay soft into Q3, fleets may defer the pre-buy rather than pull it forward, and PACCAR's operating leverage cuts both ways. A surprise EPA enforcement delay would also remove the catalyst entirely. The Q2 print on July 28 is the next stress test.

#2

A

Agilent Technologies Inc
Health CareMkt cap $38.1BNext earnings Aug 26, 2026
Price
$127.06
Est. fund entry
$113.98+11.5%
Shares held
3.05M
Position value
$347.4M
Funds that added
FundPrior sharesShares nowChange
Bridgewater Associates13.1K73.7K+462.8%
Renaissance Technologies—300.3KNew position
Citadel Advisors646.2K2.00M+209.0%
Two Sigma Investments265.4K677.3K+155.2%
Retail attention 4 of 4 signals quiet
Google Trends12/100quiet
News, 30 days10 articlesquiet
Call/put OI1.10quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Aggregate share count across the watchlist tripled Q/Q (+230%), distributed evenly enough that no single filer accounts for more than ~64% of the increase. Bridgewater scaling its position 5x is the slow-money tell; the quant adds confirm the read. Agilent is a lab-instruments cyclical that has been depressed by post-COVID biopharma capex retrenchment and NIH funding worries — Q2 already showed 6.3% core revenue growth and a guidance raise, suggesting the trough is in. Institutions appear to be positioning for the second leg of the recovery as pharma R&D budgets normalize.

What would prove it wrong

If China academic/government lab demand re-deteriorates, the recovery thesis cracks fast — Agilent has meaningful China exposure. A second leg down in biopharma funding would also delay the order normalization. Stock is no longer cheap on near-term multiples.

#3

CCI

Crown Castle Inc
Real EstateMkt cap $41.0BNext earnings Jul 17, 2026
Price
$82.05
Est. fund entry
$81.31+0.9%
Shares held
3.54M
Position value
$287.8M
Funds that added
FundPrior sharesShares nowChange
Bridgewater Associates3.06K12.2K+298.2%
Renaissance Technologies565.3K856.2K+51.5%
Citadel Advisors578.0K2.22M+283.3%
Two Sigma Investments—455.6KNew position
Retail attention 4 of 4 signals quiet
Google Trends22/100quiet
News, 30 days14 articlesquiet
Call/put OI1.00quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

All four non-Berkshire funds were adding into the closing of the $8.4B fiber/small-cell divestiture (sold to Zayo and EQT/Arium). The simplification thesis is now real: Crown Castle becomes a pure-play US tower REIT with a $1B buyback authorized in May and proceeds going to debt paydown. Bridgewater going from 3K to 12K shares is small absolute but a 298% step-change in a name they had effectively skipped. Today's -4.3% reaction to closing news likely flushes the merger-arb crowd out; institutions accumulated through Q1 at an average ~$81 (vs $82 today), so they're flat on the book.

What would prove it wrong

Tower REIT cash flow is sensitive to long rates — if the 10Y backs up another 50bps, the multiple compresses regardless of operational execution. Carrier capex (T-Mobile, AT&T, Verizon) remains the gating revenue variable, and 2026 net new leasing has been guided lower than peers.

#4

TROW

T. Rowe Price Group Inc
FinancialsMkt cap $22.0BNext earnings Jul 23, 2026
Price
$107.65
Est. fund entry
$90.14+19.4%
Shares held
2.29M
Position value
$206.7M
Funds that added
FundPrior sharesShares nowChange
Bridgewater Associates21.2K34.1K+60.4%
Renaissance Technologies—86.4KNew position
Citadel Advisors597.0K1.17M+96.0%
Two Sigma Investments65.4K1.00M+1432.0%
Retail attention 4 of 4 signals quiet
Google Trends14/100quiet
News, 30 days12 articlesquiet
Call/put OI0.90quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

All four adding, aggregate position +235% Q/Q. Active-manager flows have been the canonical short for three years — T. Rowe is the contrarian re-rate candidate. May AUM hit $1.89T with $3.3B of net inflows; two-thirds of assets sit in sticky retirement/annuity vehicles. Funds bought heavily in Q1 at an estimated ~$90 average; with the stock now at ~$108 the consensus has begun to come along, but the dividend yield (>4.5%) and a market-leading retirement franchise still screen cheap if the inflow inflection is real. The set-up rhymes with the late-2016 active-manager rebound trade.

What would prove it wrong

A 10-15% market drawdown would re-open the AUM-leak narrative and pull operating leverage hard the wrong way. ETF and target-date share losses are structural, not cyclical, and a single quarter of inflows is not yet a trend. July 23 earnings is the next confirm/deny.

#5

ACM

AECOM
IndustrialsMkt cap $10.5BNext earnings Aug 3, 2026
Price
$68.81
Est. fund entry
$84.82-18.9%
Shares held
2.09M
Position value
$177.0M
Funds that added
FundPrior sharesShares nowChange
Bridgewater Associates42.7K183.2K+329.2%
Renaissance Technologies637.6K662.3K+3.9%
Citadel Advisors546.1K734.3K+34.4%
Two Sigma Investments387.2K506.6K+30.8%
Retail attention 4 of 4 signals quiet
Google Trends10/100quiet
News, 30 days8 articlesquiet
Call/put OI1.20quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Most distributed accumulation in this scan — no single fund accounts for more than 40% of the share increase, and Bridgewater quadrupled its position. AECOM is the design/consulting layer behind transportation, water, energy and increasingly data-center build-out; the company recently flagged AI-enabled design wins and raised full-year guidance. The notable wrinkle: estimated Q1 average entry was ~$85 vs $69 today, meaning institutions are sitting on losses and still accumulating. That pattern — slow-money adding into weakness on a name with rising backlog — is the cleanest contrarian setup in the cohort.

What would prove it wrong

Government/Middle East exposure is a real headline risk; budget continuing-resolution turbulence or geopolitics can stall project starts. The stock's underperformance YTD has a reason — backlog conversion has been slower than the order book suggests, and another quarter of that erodes the thesis.

All scans

Based on public SEC 13F filings. Funds file them up to 45 days after each quarter ends, so they show positions at quarter-end, not today. Average entry prices are estimates (filing value ÷ shares) — 13F filings don't report cost basis. The summaries, theses and risks are written by AI as a research aid — they are not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Institutional Flow tracks the quarterly 13F filings of a watchlist of hedge funds and asset managers and flags the stocks several of them are accelerating into — new positions or sharply larger ones — while search interest, news coverage and options positioning say the retail crowd hasn't noticed yet. It is free, and a new scan is posted every Saturday by 9:00 AM ET. How to read Institutional Flow →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartCreate a free account

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.